Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04595565
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2020-04-07
Brief Title:
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group
Organization Data
Organization:
German Breast Group
Class:
OTHER
Study ID:
GBG102 - SASCIA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German Breast Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| UNICANCER | OTHER |
| Gilead Sciences | INDUSTRY |
| Austrian Breast Colorectal Cancer Study Group | NETWORK |
| Spanish Breast Cancer Research Group GEICAM | UNKNOWN |
| ETOP IBCSG Partners Foundation | NETWORK |
| Cancer Trials Ireland | NETWORK |